中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 2
Feb.  2001
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2001  >  17(2): 97-98

自身免疫性肝炎的诊断——附一例报告

  • Published Date: 2001-02-20
    Abstract
  • To enhance the understanding of autoimmune hepatitis, a 13-year old girl with autoimmune hepatitis was reported here. The diagnosis was confirmed by abnormal parameters of serum biochemistry (elevated aminotransferases, high titers of autoantibodies and immunoglobulins) and liver histology, excluding all other possible etiology factors. Whenever the liver functions were abnormal with unknown etiology, it is important that autoimmune hepatitis should be considered as one of the differential diagnosis. A brief review of the literature about clinical manifestations and diagnosis of autoimmune hepatitis was made.

     

    • FullText(HTML)
    • References(10)
  • [1]JohnsonPJ, McFarlaneIG Meetingreport :Internationalautoimmunehepatitisgroup [J] Hepatology , 1993, 18∶998
    [][2 ]Anonymous InternationalWorkingPartyReport:Terminologyofchronichepatitis [J] AmJGastroenterol, 1995 , 90∶181
    [3]AlvarezF , BergPA , BianchiFB , etal Internationalautoimmunehepatitis groupreport :reviewofcriteriafordiagnosisofautoimmunehepatitis [J] JHepatol, 1999, 31∶92 9
    [4]McFarlaneIG Therelationshipbetweenautoimmunemarkersanddifferentclinicalsyndromesinautoimmunehepatitis [J] Gut, 1998, 42∶5 99
    [][5 ]CzajaAJ, CarpenterHA , SantrachPJ, etal SignificanceofHLADR4intype 1autoimmunehepatitis [J] Gastroenterology , 1993, 10 5∶15 0 2
    [][6 ]TodaG , ZeniyaM , WatanabeF , etal PresentstatusofautoimmunehepatitisinJapan -correlatingthecharacteristicswithinternationalcriteriainanareawithahighrateofHCVinfection[J] JHepatol, 1997, 2 6∶12 0 7
    [7]周建明 , 董学林 老年人自身免疫性肝炎 [J] 日本医学介绍 , 1998, 19∶32 2
    [8]CzajaAJandCarpenterHA Validationofscoringsystemfordiagnosisofautoimmunehepatitis [J] DigDisSci, 1996 , 41∶30 5
    [9]BianchiFB , CassaniF , LenziM , etal Impactofinternationalautoimmunehepatitis groupscoringsystemindefinitionofautoimmunehepatitis AnItalianexpreience [J] DigDisSci, 1996 , 41∶16 6
    [][10 ]赵鸿 , 斯崇文 自身免疫性肝炎的诊断 [J] 中国综合临床 , 2 0 0 1, 3 (印刷中 )
    • Relative Articles

  • Relative Articles

    [1]Mengting ZHOU, Hongmei HAN. A diagnosis of atypical autoimmune hepatitis: A case report[J]. Journal of Clinical Hepatology, 2022, 38(11): 2565-2567. doi: 10.3969/j.issn.1001-5256.2022.11.024
    [2]Lin HAN, Mingyue ZHANG, Ying SUN. Role of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain in the immune mechanism of autoimmune hepatitis and its prospects in treatment[J]. Journal of Clinical Hepatology, 2022, 38(3): 656-659. doi: 10.3969/j.issn.1001-5256.2022.03.034
    [3]Zhang HaiPing, Yan HuiPing. Research advances in autoantibodies in autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 749-753. doi: 10.3969/j.issn.1001-5256.2020.04.007
    [4]WANG WeiZhao, ZHU QinLing, XIANG XiaoXing, MA Li, GU Da, TONG Cong, WANG TingTing, HE JiaJun, LIU Jun, WANG Lu, CHEN ChaoWu. Expression and significance of OX40/OX40L in peripheral blood of patients with autoimmune hepatitis,primary biliary cholangitis,and their overlap syndrome[J]. Journal of Clinical Hepatology, 2020, 36(12): 2740-2745. doi: 10.3969/j.issn.1001-5256.2020.12.020
    [5]Feng Ying, Zhou GuiQin, Yang Li, Li Bin, Wang XianBo. Autoimmune hepatitis-associated liver cirrhosis with primary immune thrombocytopenia: A case report[J]. Journal of Clinical Hepatology, 2020, 36(4): 879-880. doi: 10.3969/j.issn.1001-5256.2020.04.035
    [6]Xue Mei, Shen Yi, Shen MengYi, Fan XiaoLi, Men RuoTing, Yang Li. Autoimmune hepatitis-related autoantibodies and their clinical significance[J]. Journal of Clinical Hepatology, 2019, 35(6): 1392-1396. doi: 10.3969/j.issn.1001-5256.2019.06.048
    [7]Sheng JianHui, Sun Li, Tan HuiYing, Tan YouWen. Roxithromycin-induced autoimmune hepatitis:a case report[J]. Journal of Clinical Hepatology, 2018, 34(5): 1086-1087. doi: 10.3969/j.issn.1001-5256.2018.05.032
    [8]Xiong KeGong, Ke KunYu, Kong JinFeng, Liu LiJuan, Chen LiFang, Lin XiaoQin. Expression of programmed death-ligand 1 on peripheral blood T cells and its correlation with liver inflammation grade in patients with type 1 autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(6): 1248-1252. doi: 10.3969/j.issn.1001-5256.2018.06.023
    [9]Lu: Jing, Xing Feng, Yuan JiLi, Liu ChengHai. A case of autoimmune hepatitis with positive hepatitis C antibody[J]. Journal of Clinical Hepatology, 2016, 32(5): 957-959. doi: 10.3969/j.issn.1001-5256.2016.05.035
    [10]Zhang Jun, Wang QiXia, Ma Xiong. Advances in immunological treatment of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2016, 32(10): 1874-1877. doi: 10.3969/j.issn.1001-5256.2016.10.010
    [11]Li YanLi, Zhao Yan, Yan HuiPing. Evolution of regulatory T cells in pathogenesis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(5): 332-334.
    [12]Wang TaiLing, Zhao XinYan. Pathological features of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2011, 27(6): 577-580.
    [13]Zhao Qing, Xin ShaoJie, Hou Jun, Hu Yan, Mao PanYong. Detection high mobility group box-1 protein in autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2009, 25(2): 118-119.
    [15]Zhao Yan, Yan HuiPing, Tan YuFen, Liu Yan, Ma DongMei, Feng Xia, Li WeiHua. Clinical and laboratory characters of the liver dysfunctional patients with antibodies to double-stranded DNA.[J]. Journal of Clinical Hepatology, 2008, 24(1): 10-12.
    [17]Wang JingQuan, Cui ShiChang, Yan HuiPing, Dong ShengShan, Li DongCeng, Zhu RenPing. The clinical observation of autoantibody in autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(1): 12-13.
    [18]Tan YouWen, Wu JianCheng, Wu XueJun. Efficacy of ursodeoxycholic acid in the treatment of type Ⅰ autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(5): 283-284.
    [20]Zhang ShiBin, Yan HuiPing, Tao MingLing, He LiXiang, Wang JunTao. Clinical Study of the Diagnostic Scoring System of Autoimmune Hepatitis[J]. Journal of Clinical Hepatology, 2002, 18(6): 330-332.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 2.1 %FULLTEXT: 2.1 %META: 95.2 %META: 95.2 %PDF: 2.7 %PDF: 2.7 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 2.4 %其他: 2.4 %其他: 0.2 %其他: 0.2 %China: 0.3 %China: 0.3 %Reynoldsburg: 0.2 %Reynoldsburg: 0.2 %Russian Federation: 0.2 %Russian Federation: 0.2 %三门峡: 0.3 %三门峡: 0.3 %上海: 1.4 %上海: 1.4 %东莞: 0.2 %东莞: 0.2 %东营: 0.2 %东营: 0.2 %中卫: 5.3 %中卫: 5.3 %临汾: 0.2 %临汾: 0.2 %丹东: 0.2 %丹东: 0.2 %丽水: 0.2 %丽水: 0.2 %乌兰察布: 0.2 %乌兰察布: 0.2 %九江: 0.2 %九江: 0.2 %佛山: 0.3 %佛山: 0.3 %元朗新墟: 0.2 %元朗新墟: 0.2 %六盘水: 0.2 %六盘水: 0.2 %兰州: 0.2 %兰州: 0.2 %北京: 26.1 %北京: 26.1 %十堰: 0.2 %十堰: 0.2 %南充: 0.2 %南充: 0.2 %南宁: 0.3 %南宁: 0.3 %南阳: 0.2 %南阳: 0.2 %厦门: 0.2 %厦门: 0.2 %台州: 0.5 %台州: 0.5 %合肥: 0.2 %合肥: 0.2 %吉林: 0.5 %吉林: 0.5 %呼和浩特: 0.8 %呼和浩特: 0.8 %和田: 0.2 %和田: 0.2 %咸阳: 0.2 %咸阳: 0.2 %哈尔滨: 0.3 %哈尔滨: 0.3 %唐山: 0.2 %唐山: 0.2 %四平: 0.3 %四平: 0.3 %大同: 0.2 %大同: 0.2 %大理: 0.2 %大理: 0.2 %大连: 0.3 %大连: 0.3 %天水围: 0.2 %天水围: 0.2 %天津: 1.6 %天津: 1.6 %太原: 0.3 %太原: 0.3 %宁波: 0.2 %宁波: 0.2 %安康: 0.3 %安康: 0.3 %宜春: 0.2 %宜春: 0.2 %宝鸡: 0.2 %宝鸡: 0.2 %宣城: 0.5 %宣城: 0.5 %巴中: 0.2 %巴中: 0.2 %巴音郭楞: 0.2 %巴音郭楞: 0.2 %广州: 1.3 %广州: 1.3 %廊坊: 0.2 %廊坊: 0.2 %开封: 0.2 %开封: 0.2 %张家口: 1.8 %张家口: 1.8 %徐州: 0.5 %徐州: 0.5 %新余: 0.2 %新余: 0.2 %日喀则: 0.2 %日喀则: 0.2 %昆明: 0.3 %昆明: 0.3 %晋城: 0.3 %晋城: 0.3 %朝阳: 0.2 %朝阳: 0.2 %来宾: 0.3 %来宾: 0.3 %杭州: 1.4 %杭州: 1.4 %枣庄: 0.3 %枣庄: 0.3 %桂林: 0.2 %桂林: 0.2 %武汉: 0.3 %武汉: 0.3 %毕节: 0.2 %毕节: 0.2 %汉中: 0.2 %汉中: 0.2 %泉州: 0.2 %泉州: 0.2 %泰州: 0.2 %泰州: 0.2 %洛阳: 0.6 %洛阳: 0.6 %济源: 0.2 %济源: 0.2 %海北: 0.2 %海北: 0.2 %海口: 0.6 %海口: 0.6 %海西: 0.2 %海西: 0.2 %淮北: 0.2 %淮北: 0.2 %深圳: 0.8 %深圳: 0.8 %温州: 0.3 %温州: 0.3 %湖州: 0.6 %湖州: 0.6 %湘潭: 0.2 %湘潭: 0.2 %漳州: 0.3 %漳州: 0.3 %濮阳: 0.2 %濮阳: 0.2 %烟台: 0.2 %烟台: 0.2 %盐城: 0.5 %盐城: 0.5 %盘锦: 0.2 %盘锦: 0.2 %石家庄: 0.3 %石家庄: 0.3 %秦皇岛: 0.2 %秦皇岛: 0.2 %肇庆: 0.2 %肇庆: 0.2 %芒廷维尤: 13.9 %芒廷维尤: 13.9 %苏州: 0.5 %苏州: 0.5 %莫斯科: 0.2 %莫斯科: 0.2 %萍乡: 0.2 %萍乡: 0.2 %蚌埠: 0.2 %蚌埠: 0.2 %衡水: 0.2 %衡水: 0.2 %衢州: 0.3 %衢州: 0.3 %西双版纳: 0.3 %西双版纳: 0.3 %西宁: 17.1 %西宁: 17.1 %西安: 0.3 %西安: 0.3 %许昌: 0.2 %许昌: 0.2 %贵阳: 0.5 %贵阳: 0.5 %运城: 0.2 %运城: 0.2 %通化: 0.2 %通化: 0.2 %遵义: 0.2 %遵义: 0.2 %重庆: 0.6 %重庆: 0.6 %金华: 0.3 %金华: 0.3 %银川: 0.3 %银川: 0.3 %锦州: 0.2 %锦州: 0.2 %长春: 1.9 %长春: 1.9 %长沙: 1.0 %长沙: 1.0 %青岛: 0.2 %青岛: 0.2 %马鞍山: 0.2 %马鞍山: 0.2 %鹤岗: 0.2 %鹤岗: 0.2 %黔南: 0.2 %黔南: 0.2 %齐齐哈尔: 0.2 %齐齐哈尔: 0.2 %其他其他ChinaReynoldsburgRussian Federation三门峡上海东莞东营中卫临汾丹东丽水乌兰察布九江佛山元朗新墟六盘水兰州北京十堰南充南宁南阳厦门台州合肥吉林呼和浩特和田咸阳哈尔滨唐山四平大同大理大连天水围天津太原宁波安康宜春宝鸡宣城巴中巴音郭楞广州廊坊开封张家口徐州新余日喀则昆明晋城朝阳来宾杭州枣庄桂林武汉毕节汉中泉州泰州洛阳济源海北海口海西淮北深圳温州湖州湘潭漳州濮阳烟台盐城盘锦石家庄秦皇岛肇庆芒廷维尤苏州莫斯科萍乡蚌埠衡水衢州西双版纳西宁西安许昌贵阳运城通化遵义重庆金华银川锦州长春长沙青岛马鞍山鹤岗黔南齐齐哈尔

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2351) PDF downloads(826) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[1794]YesterdayPV[3166]TodayIP[209]TodayPV[336]Online[13]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return